From diagnosis to treatment and in terms of medicines manufactured, healthcare biotechnology is a
Some 20-30 million Europeans are affected by rare diseases.
The European biotech industry is calling for a robust and transparent framework in which HTA woul
Biotechnology aims to target the causes of diseases rather than just the symptoms.
Biotechnology provides powerful tools to develop diagnostics and treatments for orphan diseases.